Literature DB >> 8557868

Paralysis has no effect on chest wall and respiratory system mechanics of mechanically ventilated, sedated patients.

G Conti1, V Vilardi, M Rocco, R A DeBlasi, A Lappa, M Bufi, M Antonelli, A Gasparetto.   

Abstract

OBJECTIVE: To evaluate the separate effects of sedation and paralysis on chest wall and respiratory system mechanics of mechanically ventilated, critically ill patients.
SETTING: ICU of the University "La Sapienza" Hospital, Rome. PATIENTS AND PARTICIPANTS: 13 critically ill patients were enrolled in this study. All were affected by disease involving both lungs and chest wall mechanics (ARDS in 4 patients, closed chest trauma without flail chest in 4 patients, cardiogenic pulmonary oedema with fluidic overload in 5 patients). MEASUREMENTS AND
RESULTS: Respiratory system and chest wall mechanics were evaluated during constant flow controlled mechanical ventilation in basal conditions (i.e. with the patients under apnoic sedation) and after paralysis with pancuronium bromide. In details, we simultaneously recorded airflow, tracheal pressure, esophageal pressure and tidal volume; with the end-inspiratory and end-expiratory airway occlusion technique we could evaluate respiratory system and chest wall elastance and resistances. Lung mechanics was evaluated by subtracting chest wall from respiratory system data. All data obtained in basal conditions (with the patients sedated with thiopental or propofol) and after muscle paralysis were compared using the Student's t test for paired data. The administration of pancuronium bromide to sedated patients induced a complete muscle paralysis without producing significant modification both to the viscoelastic and to the resistive parameters of chest wall and respiratory system.
CONCLUSIONS: This study demonstrates the lack of additive effects of muscle paralysis in mechanically ventilated, sedated patients. Also in view of the possible side effects of muscle paralysis, our results question the usefulness of generalized administration of neuromuscular blocking drugs in mechanically ventilated patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557868     DOI: 10.1007/bf01700963

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  24 in total

1.  Prolonged weakness after long-term infusion of vecuronium bromide.

Authors:  Y Kupfer; T Namba; E Kaldawi; S Tessler
Journal:  Ann Intern Med       Date:  1992-09-15       Impact factor: 25.391

2.  Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man.

Authors:  P R Westbrook; S E Stubbs; A D Sessler; K Rehder; R E Hyatt
Journal:  J Appl Physiol       Date:  1973-01       Impact factor: 3.531

3.  Pancuronium bromide in the intensive care unit: a case of overdose.

Authors:  R H Vandenbrom; J M Wierda
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

4.  Prolonged paralysis after treatment with neuromuscular junction blocking agents.

Authors:  J L Gooch; M R Suchyta; J M Balbierz; J H Petajan; T P Clemmer
Journal:  Crit Care Med       Date:  1991-09       Impact factor: 7.598

5.  Neuromuscular blockade in the intensive care unit. More than we bargained for.

Authors:  J Hansen-Flaschen; J Cowen; E C Raps
Journal:  Am Rev Respir Dis       Date:  1993-01

6.  Risk factors for hydrocortisone myopathy in acute severe asthma.

Authors:  C D Shee
Journal:  Respir Med       Date:  1990-05       Impact factor: 3.415

7.  Respiratory mechanics in the normal dog determined by expiratory flow interruption.

Authors:  J H Bates; K A Brown; T Kochi
Journal:  J Appl Physiol (1985)       Date:  1989-12

8.  Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey.

Authors:  J H Hansen-Flaschen; S Brazinsky; C Basile; P N Lanken
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

9.  A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants.

Authors:  H T Klessig; H J Geiger; M J Murray; D B Coursin
Journal:  Crit Care Med       Date:  1992-09       Impact factor: 7.598

10.  Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both.

Authors:  M Hirano; B R Ott; E C Raps; C Minetti; L Lennihan; N P Libbey; E Bonilla; A P Hays
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

View more
  6 in total

1.  Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.

Authors:  Maria Bolaki; Vassilis Amargianitakis; Dimitris Georgopoulos; Christophe Guervilly; Laurent Papazian
Journal:  Intensive Care Med       Date:  2017-02-20       Impact factor: 17.440

Review 2.  Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.

Authors:  Jeremy Bourenne; Sami Hraiech; Antoine Roch; Marc Gainnier; Laurent Papazian; Jean-Marie Forel
Journal:  Ann Transl Med       Date:  2017-07

3.  Pressure-volume curves with and without muscle paralysis in acute respiratory distress syndrome.

Authors:  François Decailliot; Alexandre Demoule; Salvatore Maurizio Maggiore; Bjorn Jonson; Philippe Duvaldestin; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-07-07       Impact factor: 17.440

4.  Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.

Authors:  Christophe Guervilly; Magali Bisbal; Jean Marie Forel; Malika Mechati; Samuel Lehingue; Jeremy Bourenne; Gilles Perrin; Romain Rambaud; Melanie Adda; Sami Hraiech; Elisa Marchi; Antoine Roch; Marc Gainnier; Laurent Papazian
Journal:  Intensive Care Med       Date:  2016-12-24       Impact factor: 17.440

5.  Respiratory physiotherapy vs. suction: the effects on respiratory function in ventilated infants and children.

Authors:  Eleanor Main; Rosemary Castle; Di Newham; Janet Stocks
Journal:  Intensive Care Med       Date:  2004-05-06       Impact factor: 17.440

6.  A fresh look at paralytics in the critically ill: real promise and real concern.

Authors:  David Price; Nicholas J Kenyon; Nicholas Stollenwerk
Journal:  Ann Intensive Care       Date:  2012-10-12       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.